Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Expected To Reach $2.78 Billion By 2030 At 8.3% CAGR

The global market for ERCP procedures experienced substantial expansion recently, with projections indicating continued robust growth. This market is expected to advance from an estimated $1.86 billion in 2025 to $2.03 billion by 2026, reflecting a compound annual growth rate of 8.6%. Key factors contributing to this growth during the preceding period included the increasing incidence of gallstones, an aging demographic, the widespread burden of gastrointestinal diseases, the broader adoption of endoscopy within hospitals, and the rise of imaging-guided interventions.

The market for endoscopic retrograde cholangiopancreatography (ERCP) is poised for considerable expansion in the upcoming years, projected to reach $2.79 billion by 2030 with a compound annual growth rate (CAGR) of 8.3%. This anticipated growth stems from several key drivers, including enhanced endoscopic training programs, improvements in the early detection of pancreatic conditions, an increase in therapeutic procedures, upgraded hospital facilities, and a growing patient preference for minimally invasive treatments. During this forecast period, significant market trends are expected to emerge, such as a rise in the prevalence of biliary disorders, a greater adoption of therapeutic endoscopy, an overall increase in minimally invasive gastrointestinal interventions, the establishment of more advanced endoscopy units, and a heightened emphasis on the prompt diagnosis of pancreatic ailments.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20770&type=smp

Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Expansion Drivers: What Is Shaping Future Growth?

The expanding incidence of digestive system ailments is anticipated to be a primary catalyst for the advancement of the endoscopic retrograde cholangiopancreatography (ERCP) market in the future. These digestive system conditions encompass a wide spectrum of disorders affecting the entire gastrointestinal system, from the mouth to the anus, and also include associated organs like the liver, gallbladder, and pancreas. Factors contributing to the rise in these conditions include shifts in eating habits, an aging global population, increased antibiotic consumption, changes in lifestyle, and environmental impacts. ERCP serves as a crucial tool in managing patients with gastrointestinal problems by offering a less invasive approach for both identifying and resolving obstructions or abnormalities within the bile and pancreatic ducts, such as gallstones, blockages, growths, or infections. As an illustration, data from the American Cancer Society indicated an estimated 26,890 new stomach cancer diagnoses in the United States in January 2024, with projections of approximately 10,880 fatalities from this cancer. Consequently, the growing number of gastrointestinal conditions directly fuels the expansion of the ERCP market.

Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Segments: Where Are The Largest Growth Opportunities?

The endoscopic retrograde cholangiopancreatography (ercp) market covered in this report is segmented –

1) By Product: Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices

2) By Application: Biliary Sphincterotomy, Biliary Dilatation, Biliary Stenting, Pancreatic Sphincterotomy, Pancreatic Duct Dilatation, Pancreatic Duct Stentin

3) By End User: Hospitals And Clinics, Ambulatory Surgery Centers, Other End Users

Subsegments:

1) By Endoscopes: Flexible Endoscopes, Semi-Rigid Endoscopes, High-Resolution Endoscopes

2) By Endotherapy Devices: Stone Extraction Devices, Balloon Dilatation Catheters, Stents, Biopsy Forceps

3) By Visualization Systems: High-Definition Visualization Systems, Endoscopic Imaging Systems, Video Endoscopes

4) By Energy Devices: Electrosurgical Devices, Laser Devices, Argon Plasma Coagulation Systems

Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Strategic Trends: What Is Defining The Next Phase Of Growth?

Key players in the ERCP market are actively pursuing technological advancements, exemplified by the development of cholangioscope direct visualization systems, which aim to deliver superior, high-definition direct imaging of the bile and pancreatic ducts. This sophisticated medical instrument offers enhanced visualization capabilities for these critical anatomical structures during ERCP interventions. As an illustration, in July 2024, the UK firm Penlon Limited introduced its VedVision Cholangioscope Direct Visualisation System, a cutting-edge device engineered for precise, high-resolution direct viewing of the bile and pancreatic ducts, thereby improving diagnostic accuracy and therapeutic effectiveness in ERCP procedures. The system is equipped with a 2 mm accessory channel and a specialized guidewire channel facilitating secure passage, complemented by a comprehensive suite of accessories including biopsy forceps, stone retrieval baskets, cytology brushes, and polypectomy snares.

Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Major Participants And Competitive Dynamics

Major companies operating in the endoscopic retrograde cholangiopancreatography (ercp) market are Medtronic plc, Fujifilm Holdings Corporation, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Ottomed Endoscopy, W. L. Gore & Associates Inc., Streis plc, Cook Group, KARL STORZ SE & Co. KG, CONMED Corporation, PENTAX Medical Inc., AMBU Inc., Samsung Medison Co. Ltd., Medi-Globe GmbH, Telemed System Inc., Micro-Tech Endoscopy Inc., Hobbs Medical Inc., Shaili Endoscopy Pvt. Ltd.

Access The Complete Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Report:

https://www.thebusinessresearchcompany.com/report/endoscopic-retrograde-cholangiopancreatography-ercp-global-market-report

Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Global Footprint: Which Region Holds Market Leadership?

North Americawas the largest region in the endoscopic retrograde cholangiopancreatography (ERCP) market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the endoscopic retrograde cholangiopancreatography (ercp) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.